Article
The effects of polymorphisms in CYP2C19, ATP-binding cassette transporter B1, and paraoxonase-1 on clopidogrel treatment of Uygur patients following percutaneous coronary intervention.
European journal of clinical pharmacology - 1 Nov 2021
Wang Tingting, Li Hongjian, Wang Fengxia, Sun Li, Yu Luhai
Abstract excerpt
BACKGROUND: Acute coronary syndrome (ACS) carries a high mortality in Uygur populations. Percutaneous coronary intervention (PCI) is a safe treatment for patients with ACS. Clopidogrel reduces the risk for recurrent cardiovascular events after PCI; however, its activity is influenced by cytochrome P450 (CYP450), ATP-binding cassette transporter B1 (ABCB1), and paraoxonase-1 (PON1). OBJECTIVES: To assess the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
